SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001274644-14-000013
Filing Date
2014-08-13
Accepted
2014-08-13 16:23:22
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocera2q-201410q.htm 10-Q 769720
2 EXHIBIT 10.2 2Q 2014 ocrxexhibit1022q2014.htm EX-10.2 47248
3 EXHIBIT 31.1 2 Q 2014 ocrxexhibit3112q2014.htm EX-31.1 16600
4 EXHIBIT 31.2 2Q 2014 ocrxexhibit3122q2014.htm EX-31.2 16561
5 EXHIBIT 32.1 2Q 2014 ocrxexhibit3212q2014.htm EX-32.1 7536
6 EXHIBIT 32.2 2Q 2014 ocrxexhibit3222q2014.htm EX-32.2 7512
  Complete submission text file 0001274644-14-000013.txt   5954273

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ocrx-20140630.xml EX-101.INS 1031727
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocrx-20140630.xsd EX-101.SCH 24956
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocrx-20140630_cal.xml EX-101.CAL 64553
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocrx-20140630_def.xml EX-101.DEF 142093
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocrx-20140630_lab.xml EX-101.LAB 444401
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocrx-20140630_pre.xml EX-101.PRE 260880
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35119 | Film No.: 141037794
SIC: 2834 Pharmaceutical Preparations